Pasithea Therapeutics receives FDA rare pediatric disease designation for PAS-004 Apr 20, 2026 07:01AM
Pasithea Therapeutics provides updated clinical trial timelines Jan 13, 2026 07:03AM
Pasithea Therapeutics (KTTA) Prices 1.22M Share Offering at $4.10/sh Sep 27, 2024 06:02AM